Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Southern District of Florida on behalf of investors that purchased Carnival Corporation & Plc (NYSE: CCL) securities between January 28, 2020 and May 1, 2020 (the "Class Period"). Investors have until July 27, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Earlier today, Hulu announced the addition of a new "Watch Party" feature for its site to make a virtual viewing experience a built-in feature of its service. Now, media software maker Plex is also today launching its own "Watch Together" feature which works both with its own collection of on-demand content and users' personal media. The feature is launching in beta as it's still considered experimental, but will allow Plex users to invite friends on Plex to watch a TV show or movie together.
As many states begin to ease their lockdowns, a number of restaurants have started serving dine-in customers. That has led to a boost in traffic, and it might not fade as quickly as naysayers think, argues Gordon Haskett.
VANCOUVER , May 28, 2020 /CNW/ - The British Columbia Securities Commission (BCSC) has ordered a halt to the trading of securities of Vancouver -based Micron Waste Technologies Inc. The BCSC issued its order May 26 . The SEC said the temporary suspension resulted from "questions regarding the accuracy and adequacy of information in the marketplace about Micron Waste and its securities" since at least April.
Mairs and Power recently released its Q1 2020 Investor Letter, a copy of which you can download below. The Mairs and Power Growth Fund posted a return of -18.84% for the quarter, outperforming its benchmark, the S&P 500 Index which returned -19.60% in the same quarter. You should check out Mairs and Power's top 5 […]
DOOi Entertainment and rap musician HeidiBe recently announced the release of her new music video to pair with her latest single, "Laughing At You." The popular single is a sassy hit-back for those who have ever stood in another's way for no good reason. Since 2014, HeidiBe has been writing, singing, producing, and marketing her own brand of smooth, sultry rhymes characterized by an independent defiance. While steadily growing a flourishing social-media following, HeidiBe continues to add songs to a catalog that distinguishes her as a rising musical talent. "Laughing At You" is available for purchase and download on iTunes and Google Play Music.
IDC's forecast for the personal computing device market has been lowered for 2020 with shipments expected to reach 360.9 million units.
The "First Aid Kits - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
While a neatly made bed tends to lift the spirits and instills a sense of pride in the appearance of the bedroom, some individuals may not have the physical ability to perform this daily task. Fortunately, two inventors from Keizer, Ore., have designed an apparatus that can help anyone make a bed effortlessly.
The Georgia Public Service Commission (PSC) approved Georgia Power's plan to reduce its fuel rates by 17.2 percent and total billings by approximately $740 million over a two-year period. This reduction will lower the total monthly bill by approximately $5.32 for the typical residential customer using 1,000 kilowatt-hours per month beginning June 1, 2020.
Nutanix (NASDAQ: NTNX) came into its third-quarter earnings report having already given investors in peek into its numbers with a preliminary report early in May. Nonetheless, the results were better than the company had hinted. Eighty-four percent of billings came from subscriptions, and the subscription gross margin improved from 73.9% to 77.3%. Revenue from subscriptions increased 55% to $261 million, showing the strength and momentum of its subscription model.
Cellulotech, a company focused on research and development around cellulose, today announced that paper treated with the team's revolutionary chromatogeny technology has passed the blood/fluid resistance (ASTM F1862) test in an independent United States laboratory. This test demonstrates the treated paper's water barrier capabilities, paving the way for medical use, as per the current Food and Drug Administration requirements, furthering Cellulotech's ultimate goals of offering a technological paper-based solution to the material shortage in mask production. These results come after Cellulotech's technology successfully passed filtration and breathability tests in France, allowing mask production and distribution in the country.
General Electric warned a key financial metric will deteriorate in Q2, a day after reaching a deal to sell its iconic lighting.
(Bloomberg) -- YouTube’s battle against Covid-19 misinformation is causing collateral damage as the world’s largest online video service struggles to pick up on nuances of an increasingly complex and political topic.Since January, California pulmonologist Roger Seheult has posted regular medical lectures about the novel coronavirus on his YouTube channel, MedCram. His audience jumped to more than 700,000 subscribers. But as the virus spread in the spring, YouTube deleted five of the MedCram clips, including two about the controversial drug hydroxychloroquine and one about Remdesivir, an experimental Covid-19 treatment developed by Gilead Sciences Inc.Seheult appealed the decisions. Viewer complaints flooded in; one fan started a petition demanding YouTube stop “censoring” the footage. For Seheult, YouTube’s new rules were applied without explanation. “It’s like you’re in a hockey game,” he said. “And you keep getting called for penalties, but you don’t know what the penalties are.”According to YouTube, the referee made a mistake.“With the massive volume of videos on our site, sometimes we make the wrong call,” a YouTube spokesman said on Wednesday after Bloomberg News reached out for comment. “When it’s brought to our attention that a video has been removed mistakenly, we act quickly to reinstate it.” The five MedCram videos are back on the site now.The incident is another flash point in the debate over the role of internet gatekeepers like YouTube and its parent, Alphabet Inc.’s Google. On Wednesday, U.S. President Donald Trump railed against social-media companies after Twitter Inc. fact-checked some of his tweets. He’s also preparing an executive order that could limit liability protections from the largest user-generated networks: Twitter, Facebook Inc. and YouTube.At the same time, Democratic lawmakers have chastised YouTube for not removing conspiracy theories about the pandemic swiftly enough. In a letter to House Intelligence Chairman Adam Schiff, released on Thursday, YouTube Chief Executive Officer Susan Wojcicki wrote that the company’s automated systems detected a majority of “dangerous or misleading” videos about the virus. “The complex nature of misinformation online presents a number of challenges for platforms such as YouTube and I welcome your suggestions as to what we can do better,” she added.In addition to this political pressure, YouTube has been inundated with virus videos, while the pandemic has disrupted its contract workforce doing content moderation.“YouTube has a really tough job,” said Kyle Allred, MedCram’s co-founder and producer. “But the reality is: YouTube’s the second biggest search engine in the world. If our videos aren’t on YouTube, we don’t have the benefit of reaching as many people.”During the pandemic, YouTube has aggressively moderated virus videos after years of a more laissez-faire approach. The company has pulled thousands of clips for promoting misleading information or advice that conflicts with public health agencies. To filter footage, YouTube relies on viewers flagging videos, automated software and legions of human moderators.At the best of times, the system is sometimes heavy-handed or too lenient. In March, the company said it had to limit its use of human moderators, due to remote work limitations, and would lean more on machines to make decisions.YouTube’s challenge has grown even harder as medical videos pour onto the site and the debate about the pandemic response evolves from a mostly scientific discussion into a political fight.Trump has said he took hydroxychloroquine for about two weeks and the president has promoted it as a possible coronavirus therapy, despite an outcry from medical professionals about its unproven efficacy and potential side effects.At times, YouTube has filtered out sham science, such as videos promoting fake cures for Covid-19. More controversially, it has acted against doctors departing from public health advice. In April, YouTube removed videos by two doctors in Bakersfield, California, who used their YouTube channel to call for an end to social-distancing policies.Seheult, the pulmonologist, said his videos are nothing like that. Instead, MedCram clips dissect medical studies and early research, called preprints, related to the virus. Seheult narrates the findings and statistics -- low-key footage that, thanks to the pandemic, now draws a large audience.It seems Seheult was struck by YouTube’s algorithms scanning footage about Covid-19 cures. All five removed videos focused on potential treatments. YouTube says it relies on medical advisers and public agencies for guidance on how to handle videos about health issues. Yet the scientific consensus on some Covid-19 treatments is still taking shape. A study in The Lancet medical journal, released last week, linked hydroxychloroquine with increased risk of death and heart ailments.The YouTube spokesperson declined to cite the reason why the MedCram videos were initially removed, beyond noting that it was a mistake.The team behind MedCram is happy to have their work back on the world’s biggest video site. But they still feel frustrated with the minimal communication from YouTube. “We’re grateful to have our website MedCram.com where we don’t have to worry about censorship,” said Allred.(Updates with information on Trump executive order, YouTube CEO letter to Congress in eighth and ninth paragraphs.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
The Board of Directors of Citycon Oyj has today resolved to adjust the remaining quarterly instalments of the equity repayment in 2020 to further increase long-term financial stability and to strengthen the credit risk profile of the company. Following the adjustment, the Board of Directors will use a maximum total amount of EUR 0.5375 per share from its total dividend and equity repayment authorization of EUR 0.65 per share from the Annual General Meeting 2020. The Board of Directors will make separate resolutions on each distribution of the equity repayment. Citycon shall make separate announcements of such Board resolutions.The Board of Directors also decided that the Board's proposal regarding the company's dividend and/or equity repayment, which will be made later to the AGM 2021, would be set to maximum total EUR 0.50 per share for the year 2021. This is approximately 23% less than the original authorization of EUR 0.65 per share for 2020.
Two weeks ago, German outlet BimmerToday penned a dirge for the BMW M760i in Europe, the V12-powered executive sedan killed by emissions regulations that are doing a very good impression of The Reaper on enthusiast fare over there. Now the same outlet sings a lament (translated) for the 405-horsepower BMW M2 Competition and limited edition, 444-hp M2 CS, asserting they'll end production for European markets before the year is out. Production of the current BMW M2 for the European market will end by the end of the year 2020.
GAF Energy, a leading provider of roof-integrated solar solutions in North America, today announced the launch of a fully virtual sales, design, and support program for GAF Master EliteⓇ and Certified Contractors that install GAF Energy products. The new virtual services will allow roofers to maintain sales and essential services while observing expert health guidelines for social distancing during the COVID-19 crisis.
Resonate Blends, Inc. (OTCQB:KOAN), a cannabis-based holding company ("Resonate" or "the Company"), announced today an update to shareholders on the filing of its Information Statement on Schedule 14C with the Securities and Exchange Commission regarding the spin-out of Textmunication, Inc. from the holding company and its execution of several key business initiatives.
The production restart matters for Boeing stock not because the MAX is coming back. It matters for another reason: Boeing has to improve production efficiency to prepare for a rockier aviation future.
Global Laboratory Centrifuge Market 2020-2024 The analyst has been monitoring the laboratory centrifuge market and it is poised to grow by $ 224.41 million during 2020-2024 progressing at a CAGR of 3% during the forecast period. Our reports on the laboratory centrifuge market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. Read the full report: https://www.reportlinker.com/p05273071/?utm_source=PRN The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advances and an increasing number of biotechnology and pharmaceutical research studies. In addition, the growing use of molecular diagnostics in hospitals is anticipated to boost the growth of the market as well. The laboratory centrifuge market analysis includes product segment and geographic landscape. The laboratory centrifuge market is segmented as below: By Product • Benchtop centrifuges • Floor standing centrifuges By Geographic Landscape • North America • Europe • Asia • ROW This study identifies the emergence of next-generation centrifuge systems as one of the prime reasons driving the laboratory centrifuge market growth during the next few years. Also, the use of laboratory centrifuges in other fields and increased M&A; among vendors will lead to sizable demand in the market. The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our laboratory centrifuge market covers the following areas: • Laboratory centrifuge market sizing • Laboratory centrifuge market forecast • Laboratory centrifuge market industry analysis Read the full report: https://www.reportlinker.com/p05273071/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
Today, Sephora released the next evolution of its renowned Beauty Insider loyalty program. This update takes the client experience to the next level thanks to new offerings like Beauty Insider Cash, which allows clients to get instant savings on their purchase, along with other perks like point multiplier events, more sampling choices than ever, and exclusive experiences like early access to brand launches and the most coveted beauty events (whenever social distancing restrictions begin to lift and we can safely welcome clients back). These new program elements underscore Sephora’s ongoing commitment that – even in dynamic business environments – the company’s focus remains on the client’s long-term loyalty. The new enhancements round out Beauty Insider’s already robust set of offerings with even more value and choice for Sephora clients, by connecting them to what they love—their favorite brands, founders and products.
Even as states and cities slowly allow more businesses to reopen, many entrepreneurs are anxious about doing so. Nearly half of small business owners worry they cannot afford to resume normal operations following mandated closures to slow the spread of COVID-19, according to LendingTree's latest survey of small business owners. Approximately 46% of small business owners cite funding as the primary obstacle to reopening, and that once open, increased health and safety measures could further stifle sales.